about
Transformation of hematopoietic cells and activation of JAK2-V617F by IL-27R, a component of a heterodimeric type I cytokine receptorInterleukin-27: balancing protective and pathological immunityThe emerging role of Interleukin 27 in inflammatory arthritis and bone destructionDifferential effect of IL-27 on developing versus committed Th17 cells.gp130 at the nexus of inflammation, autoimmunity, and cancer.IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells.IL-27-induced gene expression is downregulated in HIV-infected subjects.Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis.A role for IL-27p28 as an antagonist of gp130-mediated signaling.A partial form of recessive STAT1 deficiency in humans.Immunization associated with erectile dysfunction based on cross-sectional and genetic analyses.Interleukin-27 ameliorates coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cellsIL-27 increases BST-2 expression in human monocytes and T cells independently of type I IFN.The biology and therapeutic potential of interleukin 27.IL27: its roles in the induction and inhibition of inflammation.The B cell transcription program mediates hypomethylation and overexpression of key genes in Epstein-Barr virus-associated proliferative conversion.Advances in understanding the anti-inflammatory properties of IL-27.Helicobacter pylori infection in a pig model is dominated by Th1 and cytotoxic CD8+ T cell responses.Evaluating the potential of IL-27 as a novel therapeutic agent in HIV-1 infection.Interleukin 27: a double-edged sword for offense and defense.IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses.Thymic DCs derived IL-27 regulates the final maturation of CD4(+) SP thymocytes.Interleukin-27: biological properties and clinical application.New directions in the basic and translational biology of interleukin-27.The presence of interleukin-27 during monocyte-derived dendritic cell differentiation promotes improved antigen processing and stimulation of T cells.Dual Roles of IL-27 in Cancer Biology and Immunotherapy.IL-27 Directly Enhances Germinal Center B Cell Activity and Potentiates Lupus in Sanroque Mice.Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo.Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model.B-cell-activating factor inhibits CD20-mediated and B-cell receptor-mediated apoptosis in human B cells.Hepatitis C viraemia reversibly maintains subset of antigen-specific T-bet+ tissue-like memory B cells.Regulation and Immune Function of IL-27.Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode.Signaling events involved in interleukin 27 (IL-27)-induced proliferation of human naive CD4+ T cells and B cells.Rather than interleukin-27, interleukin-6 expresses positive correlation with liver severity in naïve hepatitis B infection patients.IL-27 increases the proliferation and effector functions of human naïve CD8+ T lymphocytes and promotes their development into Tc1 cells.Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma.Circulating IL-27 Is Elevated in Rheumatoid Arthritis Patients.Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.A novel IL-23p19/Ebi3 (IL-39) cytokine mediates inflammation in Lupus-like mice.
P2860
Q24676526-9BAA7E3F-174C-4E75-89EF-9A4DAC7D588FQ26830400-ECA7D46E-A163-42AA-A63F-FF8C73E17C9CQ26995207-9EBA39A1-8799-408E-A99C-7D04D68E2B8AQ33984278-63D30199-4A15-4C08-8AD7-C78508298577Q34378756-4DB87B65-CCF3-4097-8656-B501B5A07E03Q34420821-8C740B26-F610-4053-B2D2-5BB3BA82DF1FQ34438335-26A771CC-4C8D-4947-9E0F-9715D5935A70Q34636409-209FF7AA-B8C2-4106-B03E-F3D8D692E934Q34688139-F3C2CF59-6E7B-4322-89B2-87675C16E09AQ34980624-E57EFC3E-2764-4571-8217-975B56EC6C70Q35365403-7977E2FB-21F7-47C0-A7EF-D4F473238F69Q36294384-5383232D-43B1-4B9F-B50A-26D51C62F0D0Q36463634-EAE1F9D8-7EBC-4E39-82AF-6E678593C391Q36733744-7A0C3B1A-38C9-4336-AD99-839989FF74DEQ36784915-BD5BEE2C-A501-4307-B08A-03F610215C34Q36872499-C86B4D4C-059E-4F82-B980-960996E172B2Q37124028-E87FA69A-F3ED-46C3-8F71-403F71BBF97CQ37264581-61DDFD9E-08A8-4231-B324-C74740809AE4Q37365279-BB61C463-3599-4FFA-B827-55E453C8E683Q37607910-D0A33848-92CD-4E33-878B-88D44571BE86Q37684639-125E7783-B432-4ACB-BA30-1E5F5FABA85EQ37747271-412FDEB5-09C9-44CB-ABDC-87AEE895BD4CQ37792908-F0F13104-35E8-4346-B468-A4E0C76EE8E2Q37969347-DDFB7765-AD47-49A6-95EE-AF3EABEA3ADCQ39107845-DFD0A8B2-01DF-4C90-8A46-94E1509BA18EQ39158943-07B6712A-1CCF-424F-8788-EAF333A9ACBFQ39399282-117BFB34-2084-47C0-A102-E0B3E085E142Q39423588-84C16DBC-D167-4502-8F74-A7DB8845906EQ39736137-F42FBA7F-EB92-461E-908B-BFA8EFA031CFQ39973901-A9734CC3-CDEC-4FC4-BA48-6D255D130940Q40420686-1D17D81D-6EC1-4FBB-8651-09778FA184ACQ40508641-699211BA-F291-45D4-BB4C-E4D4C0561374Q41514200-ADD813A3-FCDC-442A-81B0-50901B00B4E9Q41887169-F6988651-B010-4515-8D12-A0DB0D57F128Q44445036-948926ED-19C9-43F2-8D98-96E976C4F3C2Q45362711-10EC4667-9766-4F7B-B7BB-F45BA11B2378Q45756098-1D096D33-592A-4865-AB1B-D2F2C17BB96DQ51313776-687F6B47-5868-4FCD-A420-608E41BEFD16Q52723506-4D9ECC07-69F4-4893-A4D6-65FCCE30949AQ53136156-2E2A9005-746E-4412-80F2-BAF4A83E92DA
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Differential effects of IL-27 on human B cell subsets
@ast
Differential effects of IL-27 on human B cell subsets
@en
Differential effects of IL-27 on human B cell subsets
@nl
type
label
Differential effects of IL-27 on human B cell subsets
@ast
Differential effects of IL-27 on human B cell subsets
@en
Differential effects of IL-27 on human B cell subsets
@nl
prefLabel
Differential effects of IL-27 on human B cell subsets
@ast
Differential effects of IL-27 on human B cell subsets
@en
Differential effects of IL-27 on human B cell subsets
@nl
P2093
P1476
Differential effects of IL-27 on human B cell subsets
@en
P2093
Emilie Bardel
Frédérique Larousserie
Josy Froger
Odile Devergne
Pascaline Charlot
Robert A Kastelein
P304
P356
10.4049/JIMMUNOL.176.10.5890
P407
P577
2006-05-15T00:00:00Z